the upfront payments are small. this is for obvious reasons- the royalty is where the money is, not the upfront. You need to remember that Genlabs is gearing up with the kits and the sales, the E kit sales will take time to build up. The company will also be offered upfront for the HepA kit but will go for the royalty everytime. This is a commercial play and makes more sense longer term.
- Forums
- ASX - By Stock
- SLT
- bioshares - spec buy reccomendation
bioshares - spec buy reccomendation, page-5
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)